|
CMV Therapeutic Vaccine for the Treatment of Glioblastoma
|
1R41CA153845-01A1
|
$246,026
|
$246,026
|
MITCHELL, DUANE
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-03
|
$377,399
|
$188,700
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-10
|
$1,916,364
|
$1,916,364
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$4,558
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$8,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$322,823
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-05
|
$308,958
|
$308,958
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Infection and Inflammation in Adult Gliomas
|
5K07CA131505-05
|
$135,445
|
$135,445
|
Scheurer, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
|
5R01CA142664-03
|
$308,958
|
$77,240
|
YOTNDA, PATRICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma
|
5R01CA149445-02
|
$549,324
|
$549,324
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB
|
5K08CA140780-03
|
$179,910
|
$179,910
|
Gewurz, Benjamin
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-13
|
$386,387
|
$386,387
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
2R01CA047006-25
|
$565,231
|
$565,231
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
2R01CA085180-11A1
|
$701,405
|
$701,405
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
|
5R01CA131354-04
|
$359,276
|
$359,276
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of EBV Infection
|
5R01CA068051-17
|
$453,231
|
$453,231
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
2R01CA077544-11A1
|
$29,183
|
$29,183
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-07
|
$2,300,000
|
$69,000
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S1
|
$91,911
|
$1,838
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S2
|
$139,999
|
$2,800
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S3
|
$75,000
|
$1,500
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-29
|
$2,225,352
|
$44,507
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Evaluating New Targets of CMV Cellular Immunity
|
5R01CA145207-07
|
$393,139
|
$393,139
|
Zaia, John
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Antiviral actions of interferons
|
5R01CA068782-25
|
$437,142
|
$144,257
|
SEN, GANES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$334,937
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$1,697
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$2,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies
|
5R01CA161026-02
|
$410,749
|
$102,687
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA023108-34S1
|
$74,921
|
$1,498
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-34S2
|
$49,921
|
$998
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-34
|
$3,125,750
|
$62,515
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Immune surveillance in murine gammaherpesvirus infection
|
5R01CA103642-09
|
$276,154
|
$276,154
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
Viral Oncology Training Grant
|
5T32CA009111-35
|
$316,972
|
$95,092
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-38S1
|
$75,000
|
$1,500
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-38
|
$5,723,821
|
$114,476
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation
|
5R01CA140337-02
|
$325,775
|
$325,775
|
Luftig, Micah
|
DUKE UNIVERSITY
|
|
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
|
5R01CA134844-04
|
$312,186
|
$312,186
|
MITCHELL, DUANE
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$59,707
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$3,000
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$5,987
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Control of Gammaherpesvirus Replication
|
5R01CA052004-23
|
$310,549
|
$310,549
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Role of B Cells in Murine Gammaherpesvirus-68 Latency
|
5R01CA095318-08
|
$330,795
|
$330,795
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa
|
5R01CA138165-03
|
$297,837
|
$297,837
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S1
|
$116,988
|
$1,170
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S2
|
$139,999
|
$1,400
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S3
|
$74,876
|
$749
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S4
|
$50,000
|
$500
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-38S5
|
$211,800
|
$2,118
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-38
|
$11,373,047
|
$113,730
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Herpes - Other for this search: $46,738,132
|